HEADER    TRANSCRIPTION/AGONIST                   29-NOV-17   6BR2              
TITLE     STRUCTURE OF RORGT IN COMPLEX WITH A NOVEL ISOQUINOLINE INVERSE       
TITLE    2 AGONIST.                                                             
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA;                                
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1     
COMPND   5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED      
COMPND   6 ORPHAN RECEPTOR-GAMMA;                                               
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: RORC, NR1F3, RORG, RZRG;                                       
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    NUCLEAR HORMONE RECEPTOR, INVERSE AGONIST, COMPLEX, TRANSCRIPTION-    
KEYWDS   2 AGONIST COMPLEX                                                      
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    R.J.SKENE,I.HOFFMAN                                                   
REVDAT   3   13-MAR-24 6BR2    1       REMARK                                   
REVDAT   2   25-APR-18 6BR2    1       JRNL                                     
REVDAT   1   21-MAR-18 6BR2    0                                                
JRNL        AUTH   M.KONO,A.OCHIDA,T.ODA,T.IMADA,Y.BANNO,N.TAYA,S.MASADA,       
JRNL        AUTH 2 T.KAWAMOTO,K.YONEMORI,Y.NARA,Y.FUKASE,T.YUKAWA,H.TOKUHARA,   
JRNL        AUTH 3 R.SKENE,B.C.SANG,I.D.HOFFMAN,G.P.SNELL,K.UGA,A.SHIBATA,      
JRNL        AUTH 4 K.IGAKI,Y.NAKAMURA,H.NAKAGAWA,N.TSUCHIMORI,M.YAMASAKI,       
JRNL        AUTH 5 J.SHIRAI,S.YAMAMOTO                                          
JRNL        TITL   DISCOVERY OF [ CIS-3-({(5                                    
JRNL        TITL 2 R)-5-[(7-FLUORO-1,1-DIMETHYL-2,3-DIHYDRO-1                   
JRNL        TITL 3 H-INDEN-5-YL)CARBAMOYL]-2-METHOXY-7,8-DIHYDRO-1,             
JRNL        TITL 4 6-NAPHTHYRIDIN-6(5 H)-YL}CARBONYL)CYCLOBUTYL]ACETIC ACID     
JRNL        TITL 5 (TAK-828F) AS A POTENT, SELECTIVE, AND ORALLY AVAILABLE      
JRNL        TITL 6 NOVEL RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR GAMMA T 
JRNL        TITL 7 INVERSE AGONIST.                                             
JRNL        REF    J. MED. CHEM.                 V.  61  2973 2018              
JRNL        REFN                   ISSN 1520-4804                               
JRNL        PMID   29510038                                                     
JRNL        DOI    10.1021/ACS.JMEDCHEM.8B00061                                 
REMARK   2                                                                      
REMARK   2 RESOLUTION.    3.18 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC                                               
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 3.18                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 43.23                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 100.0                          
REMARK   3   NUMBER OF REFLECTIONS             : 11396                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.178                           
REMARK   3   R VALUE            (WORKING SET) : 0.175                           
REMARK   3   FREE R VALUE                     : 0.227                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 4.900                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 589                             
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 3475                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 86                                      
REMARK   3   SOLVENT ATOMS            : 18                                      
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : NULL                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 107.6                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 0.60000                                              
REMARK   3    B22 (A**2) : 0.60000                                              
REMARK   3    B33 (A**2) : -1.96000                                             
REMARK   3    B12 (A**2) : 0.30000                                              
REMARK   3    B13 (A**2) : 0.00000                                              
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): NULL          
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.411         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.323         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 43.838        
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   DISTANCE RESTRAINTS.                    RMS    SIGMA               
REMARK   3    BOND LENGTH                     (A) : NULL  ; NULL                
REMARK   3    ANGLE DISTANCE                  (A) : NULL  ; NULL                
REMARK   3    INTRAPLANAR 1-4 DISTANCE        (A) : NULL  ; NULL                
REMARK   3    H-BOND OR METAL COORDINATION    (A) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   PLANE RESTRAINT                  (A) : NULL  ; NULL                
REMARK   3   CHIRAL-CENTER RESTRAINT       (A**3) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   NON-BONDED CONTACT RESTRAINTS.                                     
REMARK   3    SINGLE TORSION                  (A) : NULL  ; NULL                
REMARK   3    MULTIPLE TORSION                (A) : NULL  ; NULL                
REMARK   3    H-BOND (X...Y)                  (A) : NULL  ; NULL                
REMARK   3    H-BOND (X-H...Y)                (A) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3   CONFORMATIONAL TORSION ANGLE RESTRAINTS.                           
REMARK   3    SPECIFIED                 (DEGREES) : NULL  ; NULL                
REMARK   3    PLANAR                    (DEGREES) : NULL  ; NULL                
REMARK   3    STAGGERED                 (DEGREES) : NULL  ; NULL                
REMARK   3    TRANSVERSE                (DEGREES) : NULL  ; NULL                
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED                 
REMARK   4                                                                      
REMARK   4 6BR2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-17.                  
REMARK 100 THE DEPOSITION ID IS D_1000231307.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 29-JUN-13                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : NULL                               
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : ALS                                
REMARK 200  BEAMLINE                       : 5.0.3                              
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.97                               
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315R                  
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
REMARK 200  DATA SCALING SOFTWARE          : HKL-2000                           
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 12017                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 3.180                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 100.0                              
REMARK 200  DATA REDUNDANCY                : 4.700                              
REMARK 200  R MERGE                    (I) : 0.06100                            
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 11.9000                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.18                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 3.23                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 100.0                              
REMARK 200  DATA REDUNDANCY IN SHELL       : 4.80                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.94000                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL                         
REMARK 200 SOFTWARE USED: PHASER                                                
REMARK 200 STARTING MODEL: NULL                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 65.94                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.61                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 2%MPD, 1.2M NAFORMATE, 0.1M HEPES 7.5,   
REMARK 280  VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K                     
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61                             
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -Y,X-Y,Z+1/3                                            
REMARK 290       3555   -X+Y,-X,Z+2/3                                           
REMARK 290       4555   -X,-Y,Z+1/2                                             
REMARK 290       5555   Y,-X+Y,Z+5/6                                            
REMARK 290       6555   X-Y,X,Z+1/6                                             
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       41.82800            
REMARK 290   SMTRY1   3 -0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   3 -0.866025 -0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000       83.65600            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   4  0.000000  0.000000  1.000000       62.74200            
REMARK 290   SMTRY1   5  0.500000  0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   5 -0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   5  0.000000  0.000000  1.000000      104.57000            
REMARK 290   SMTRY1   6  0.500000 -0.866025  0.000000        0.00000            
REMARK 290   SMTRY2   6  0.866025  0.500000  0.000000        0.00000            
REMARK 290   SMTRY3   6  0.000000  0.000000  1.000000       20.91400            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1, 2                                                    
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 2                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 465                                                                      
REMARK 465 MISSING RESIDUES                                                     
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
REMARK 465                                                                      
REMARK 465   M RES C SSSEQI                                                     
REMARK 465     SER B   477                                                      
REMARK 465     GLN B   478                                                      
REMARK 465     HIS B   479                                                      
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    SER A 266     -153.03   -108.28                                   
REMARK 500    GLN A 286      -54.99     63.95                                   
REMARK 500    GLU A 435       75.34   -101.53                                   
REMARK 500    SER A 477      -73.77    -97.92                                   
REMARK 500    GLN B 286      -56.82     67.13                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 501                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue E3S A 502                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue MPD B 501                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue E3S B 502                 
DBREF  6BR2 A  265   479  UNP    P51449   RORG_HUMAN     265    479             
DBREF  6BR2 B  265   479  UNP    P51449   RORG_HUMAN     265    479             
SEQRES   1 A  215  ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL          
SEQRES   2 A  215  CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU          
SEQRES   3 A  215  ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU          
SEQRES   4 A  215  GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET          
SEQRES   5 A  215  TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN          
SEQRES   6 A  215  TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET          
SEQRES   7 A  215  GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA          
SEQRES   8 A  215  GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA          
SEQRES   9 A  215  TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS          
SEQRES  10 A  215  TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER          
SEQRES  11 A  215  GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU          
SEQRES  12 A  215  SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR          
SEQRES  13 A  215  THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU          
SEQRES  14 A  215  GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU          
SEQRES  15 A  215  GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG          
SEQRES  16 A  215  GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU          
SEQRES  17 A  215  ARG SER LEU CYS SER GLN HIS                                  
SEQRES   1 B  215  ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL          
SEQRES   2 B  215  CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU          
SEQRES   3 B  215  ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU          
SEQRES   4 B  215  GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET          
SEQRES   5 B  215  TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN          
SEQRES   6 B  215  TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET          
SEQRES   7 B  215  GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA          
SEQRES   8 B  215  GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA          
SEQRES   9 B  215  TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS          
SEQRES  10 B  215  TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER          
SEQRES  11 B  215  GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU          
SEQRES  12 B  215  SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR          
SEQRES  13 B  215  THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU          
SEQRES  14 B  215  GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU          
SEQRES  15 B  215  GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG          
SEQRES  16 B  215  GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU          
SEQRES  17 B  215  ARG SER LEU CYS SER GLN HIS                                  
HET    MPD  A 501       8                                                       
HET    E3S  A 502      35                                                       
HET    MPD  B 501       8                                                       
HET    E3S  B 502      35                                                       
HETNAM     MPD (4S)-2-METHYL-2,4-PENTANEDIOL                                    
HETNAM     E3S (1R)-N-(4-TERT-BUTYL-3-FLUOROPHENYL)-6-METHOXY-2-[(3-            
HETNAM   2 E3S  OXO-2,3-DIHYDRO-1,2-OXAZOL-5-YL)ACETYL]-1,2,3,4-                
HETNAM   3 E3S  TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE                            
FORMUL   3  MPD    2(C6 H14 O2)                                                 
FORMUL   4  E3S    2(C26 H28 F N3 O5)                                           
FORMUL   7  HOH   *18(H2 O)                                                     
HELIX    1 AA1 SER A  266  GLU A  283  1                                  18    
HELIX    2 AA2 ARG A  288  ARG A  296  1                                   9    
HELIX    3 AA3 SER A  301  LYS A  311  1                                  11    
HELIX    4 AA4 SER A  312  ARG A  337  1                                  26    
HELIX    5 AA5 CYS A  345  MET A  365  1                                  21    
HELIX    6 AA6 GLY A  384  GLY A  392  5                                   9    
HELIX    7 AA7 CYS A  393  LEU A  410  1                                  18    
HELIX    8 AA8 SER A  413  ILE A  426  1                                  14    
HELIX    9 AA9 GLU A  435  THR A  457  1                                  23    
HELIX   10 AB1 SER A  461  LEU A  466  1                                   6    
HELIX   11 AB2 SER B  266  THR B  284  1                                  19    
HELIX   12 AB3 ARG B  288  GLN B  295  1                                   8    
HELIX   13 AB4 ARG B  296  ASN B  298  5                                   3    
HELIX   14 AB5 SER B  301  LYS B  311  1                                  11    
HELIX   15 AB6 SER B  312  ARG B  337  1                                  26    
HELIX   16 AB7 CYS B  345  ALA B  355  1                                  11    
HELIX   17 AB8 GLY B  356  MET B  365  1                                  10    
HELIX   18 AB9 GLY B  384  GLY B  392  5                                   9    
HELIX   19 AC1 CYS B  393  LEU B  410  1                                  18    
HELIX   20 AC2 SER B  413  ILE B  426  1                                  14    
HELIX   21 AC3 GLU B  435  THR B  457  1                                  23    
HELIX   22 AC4 ARG B  459  LEU B  463  5                                   5    
SHEET    1 AA1 3 TYR A 369  ASN A 370  0                                        
SHEET    2 AA1 3 THR A 375  PHE A 378 -1  O  THR A 375   N  ASN A 370           
SHEET    3 AA1 3 LYS A 381  GLY A 383 -1  O  GLY A 383   N  VAL A 376           
SHEET    1 AA2 3 TYR B 369  ASN B 370  0                                        
SHEET    2 AA2 3 THR B 375  PHE B 378 -1  O  THR B 375   N  ASN B 370           
SHEET    3 AA2 3 LYS B 381  GLY B 383 -1  O  GLY B 383   N  VAL B 376           
SITE     1 AC1  4 GLU A 304  TYR A 308  LYS A 311  ARG A 319                    
SITE     1 AC2 11 GLN A 286  CYS A 320  HIS A 323  LEU A 324                    
SITE     2 AC2 11 ARG A 364  MET A 365  PHE A 377  PHE A 378                    
SITE     3 AC2 11 GLU A 379  GLY A 380  PHE A 388                               
SITE     1 AC3  6 GLU B 290  GLU B 304  GLY B 307  TYR B 308                    
SITE     2 AC3  6 LYS B 311  ARG B 319                                          
SITE     1 AC4 10 GLN B 286  CYS B 320  HIS B 323  LEU B 324                    
SITE     2 AC4 10 ARG B 364  PHE B 377  PHE B 378  GLU B 379                    
SITE     3 AC4 10 GLY B 380  PHE B 388                                          
CRYST1   99.842   99.842  125.484  90.00  90.00 120.00 P 61         12          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.010016  0.005783  0.000000        0.00000                         
SCALE2      0.000000  0.011565  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.007969        0.00000